![Dr Sharon Hanley Dr Sharon Hanley](/img/200x200/staffpages/uploads/s12sh2/avatar/OhmqdOXjGgE80ZjoiMP18nUEpjG4jaKEMiBNqFGE.jpeg)
Senior Lecturer
- About
-
Biography
SHARON HANLEY is a cancer epidemiologist in the Department of Academic Primary Care in the Institute of Applied Health Sciences at the University of Aberdeen. She ia also a member of Aberdeen Centre for Women’s Health Research. She obtained her PhD in Public Health and Epidemiology from Hokkaido University Graduate School of Medicine in Sapporo, Japan. She also has an MA (Hons) in Modern Languages from the University of St Andrews.
Sharon has an outstanding record of public health leadership in both cervical cancer screening and the human papillomavirus (HPV) vaccination and is passionate about equity in public health outcomes. She sits on several national and international steering groups for cervical cancer control, including the Japan Cancer Society’s working group for HPV Self-sampling, the HPV Prevention and Control Board, the COVID-19 and Cancer Global Modelling Consortium and the World Health Organization reference group on Behavioural and Social Drivers (BeSD) of HPV vaccination.
Sharon strives to get as many girls as possible vaccinated against the HPV and has been invited to speak on the topic of HPV vaccine hesitancy at over 100 national and international meetings. She has also provided consultation on HPV vaccine safety to public health professionals in countries such as Ireland, Denmark and Columbia, who have faced issues similar to Japan regarding HPV vaccine hesitancy.
Her current research focuses on developing and validating a Japanese version of the BeSD tools (surveys, interview and implementation guides) and as well as how cervical screening can best meet the needs of disadvantaged groups who have poorer cervical cancer outcomes in Scotland. She is particularly interested in HPV self-sampling.,
In her free time, she volunteers for Sapporo English Medical Interpreters group, where she uses her native level proficiency in Japanese to help non-Japanese citizens access local cervical cancer screening and childhood immunization programmes.
External Memberships
PROFESSIONAL AFFILIATIONS
2020- present International Partnership for Resilience in Cancer Systems (I-PARCS)
2015- present Board Member: International HPV Prevention and Control Board
2013- present Executive Board Member: Cancer Support Hokkaido
2009- present Executive Board Member: People’s Campaign Against Female Cancers (PCAF)
2009- present Executive Board Member: Professional Women's Coalition for Sexuality and Health
2009- present Advisor and volunteer interpreter and translator: Sapporo English Medical Interpreters (SEMI)
ACADEMIC AFFILIATIONS
2021-2022 Co-Chair Scientific Program Committee (Public Health), International Papillomavirus Society
2019- present Scientific Programme Committee, European Research Organisation in Genital Infection and Neoplasia
2009-present European Research Organisation in Genital Infection and Neoplasia
2009- present International Papillomavirus Society
2009- present Japan Epidemiological Association
2009- present Japanese Society of Public Health
2009- present Japan Society for Cancer Prevention
2009- present Japan Cancer Society
2009- present Japan Society of Adolescent Health
2009- present Japan Society of Obstetrics and Gynaecology
2009- present Japan Society of Gynaecologic Cancer Screening
2009- present International Epidemiological Association
2009- present Asia-Oceania Research Organisation in Genital Infection and Neoplasia
Prizes and Awards
2021: Excellent Original Paper Award
Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling Study Lancet Public Health, 2020 Apr;5(4):e223-e234 Hokkaido University Graduate School of Medicine
2020: Excellent Teacher Award
Hokkaido University Graduate School of Medicine
2020: Daiwa Award (with the University of Hokkaido)
Japan UK collaboration using 21st century technology to improve access to and participation in cervical cancer screening programs, Anglo Japanese Daiwa Foundation, London, UK
2019: Butterfield Award (with the University of Edinburgh)
HPV based interventions for the prevention of cervical cancer, UK Sasakawa Foundation, London, UK
2016: Women in Global Science (WINGS) Award
Hokkaido University, Sapporo, Japan
2015: International Travel Award (Excellent Oral Presentation)
The Japanese HPV Vaccine Tragedy, 41st Annual Meeting of the Korean Cancer Association with International Cancer Conference, Seoul, South Korea
2015: Good Poster Award
The role of HPV self-sampling to increase cervical screening uptake, 67th Annual Congress of the Japan Society of Obstetrics and Gynaecology, Yokohama, Japan
2014: Best Oral Presentation,
Attitudes towards HPV Self-Sampling and Physician Led Cervical Screening in Japanese Women, AOGIN 2014, Peking, China
2012; Best Original Paper
Acceptance of and attitudes towards human papillomavirus vaccination in Japanese mothers of adolescent girls, Japanese Foundation for Sexual Health Medicine Tokyo, Japan
- Research
-
Funding and Grants
2020-2022 Japan Society for the Promotion of Science (JSPS): Implementation and evaluation of a nurse-led cervical screening programme: Increasing screening coverage. Co-investigator, grant holder Professor Rika Kudo, Toyama Prefectural University of Nursing, 17,680,000 yen (Grant No:19H01390)
2019-2021 Japan Society for the Promotion of Science (JSPS): Reviewing maternity care policies for achieving MDG5 in Asia: Focusing on de-medicalization and positive birth experience. Co-investigator, grant holder Professor Etsuko Matsuoka, Nara Women’s University, 15,600,000 yen (Grant No:20H04002)
2018-2020 Japan Society for the Promotion of Science (JSPS): Development and validation of a training programme for Japanese midwives to perform cervical screening. Co-investigator, grant holder Professor Tokiko Oishi, Takasaki University of Health and Welfare, 4,420,000 yen (Grant No:18K10481)
2017-2019 Japan Society for the Promotion of Science (JSPS): Increasing screening uptake: Training Japanese nurses to perform cervical screening. Co-investigator, grant holder Professor Rika Kudo, Toyama Prefectural University of Nursing, 6,240,000 yen (Grant No:17K19851)
2016-2018 Japan Society for the Promotion of Science (JSPS): A randomized-control trial assessing the impact of HPV self-sampling on cervical screening uptake rates in women 20- 29yrs: A comparative evaluation of two novel cervico-vaginal self-sampling devices. Grant holder and Principal Investigator, 16,380,000 yen (Grant No: 16H05253)
2016-2018 Japan Society for the Promotion of Science (JSPS): Attitudes Towards and Acceptance of HPV Vaccine in Japanese Mothers of Adolescents living in the UK and Australia. Grant holder and Principal Investigator, 3,640,000 yen (Grant No:16K15367)
2015-2016 Japan Society for the Promotion of Science (JSPS): HPV self-sampling: A novel method to increase screening uptake. Co-investigator, grant holder Professor Noriaki Sakuragi, Hokkaido University, 2,900,000 yen (Grant No:15K15230)
2014-2016 Japan Society for the Promotion of Science (JSPS): HPV Self-sampling: An innovative system to investigate HPV vaccine efficacy and increase cervical screening in young women. Grant holder and Principal Investigator, 3,770,000 yen (Grant No:26670323)
2013-2015 Japan Society for the Promotion of Science (JSPS): Development of educational materials for school children to promote awareness and correct understanding of cancer. Grant holder and Principal Investigator, 18,850,000 yen (Grant no:25282208)
2010-2012 Japan Society for the Promotion of Science (JSPS): Attitudes towards and acceptance of HPV vaccine in mothers of adolescent daughters: Maximizing the impact of HPV vaccination in Japan. Grant holder and Principal Investigator, 4,550,000 yen (Grant no:22590600)
Non JSPS grants
2020-2022 Anglo Japanese Daiwa Foundation: Japan UK collaboration using 21st century technology to improve access to and participation in cervical cancer screening programs. Grant holder and Principal investigator with Professor Maggie Cruickshank, University of Aberdeen. £2,500
2019-2021 National Cancer Institute (Japan): Individually Tailored Strategies for the Prevention of Cervical and Lung Cancer Co-investigator, grant holder, Dr Etsuko Saito, National Cancer Institute, 10,000,000 yen (Grant No: PJ7L210005)
2019-2022 Sasakawa Foundation: HPV based interventions for the prevention of cervical cancer. Grant holder and Principal investigator with Dr Kate Cuschieri, University of Edinburgh. £10,800
2010 Ito Foundation Travel Grant, EUROGIN 2010, 300,000 yen
- Publications
-
Page 3 of 7 Results 21 to 30 of 65
Japan's Ongoing Crisis on HPV Vaccination.
Vaccines, vol. 8, no. 3, 362Contributions to Journals: ArticlesImpact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study
The Lancet Public Health, vol. 5, no. 4, pp. e223-e234Contributions to Journals: ArticlesThe role of healthcare providers in HPV vaccination programs – A meeting report
Papillomavirus Research, vol. 8, 100183Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.pvr.2019.100183
- [ONLINE] View publication in Scopus
Political and public responses to human papillomavirus vaccination
Human Papillomavirus: Proving and Using a Viral Cause for Cancer. Elsevier, pp. 363-377, 15 pagesChapters in Books, Reports and Conference Proceedings: Chapters- [ONLINE] DOI: https://doi.org/10.1016/B978-0-12-814457-2.00022-2
- [ONLINE] View publication in Scopus
Correction: Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer.
Oncogene, vol. 38, no. 20, pp. 5257-5268Contributions to Journals: ArticlesExploring lncRNA-mediated regulatory networks in endometrial cancer cells and the tumor microenvironment: Advances and challenges
Cancers, vol. 11, no. 2, 234Contributions to Journals: Review articlesBivalent Human Papillomavirus Vaccine Effectiveness in a Japanese Population: High Vaccine-Type-Specific Effectiveness and Evidence of Cross-Protection
The journal of infectious diseases, vol. 219, no. 3, pp. 382-390Contributions to Journals: ArticlesDifferential misclassification between self-reported status and official HPV vaccination records in Japan: Implications for evaluating vaccine safety and effectiveness.
Papillomavirus Res, vol. 6, pp. 6-10Contributions to Journals: ArticlesLong Non-coding RNA NEAT1: A Novel Target for Diagnosis and Therapy in Human Tumors.
Frontiers in Genetics, vol. 9, 471Contributions to Journals: ArticlesControl of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer.
Oncogene, vol. 37, no. 39, pp. 5257-5268Contributions to Journals: Articles